Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Must have given written informed consent~* Must be ≥ 18 years of age and not of child bearing potential~* Must have an ulcer in which the presence of MRSA has been identified, but which is not clinically infected~* Must have an ulcer size not to extend beyond the inner borders of the dressing~Exclusion Criteria:~* Is a female of child bearing years or who could become pregnant~* Is \< 18 years of age~* Has an clinically infected skin ulcer~* Has a ulcer that is being treated with a topical antimicrobial agent or has been treated with a topical antimicrobial agent during 3 days prior to enrolment~* Has been using systemic antibiotics during 7 days prior to enrolment into this study~* Has an ulcer which is identified as malignant in origin (e.g. Marjolin's ulcer)~* Has an ulcer size beyond the inner borders of the dressing~* Is septic or has other signs of an invasive infection~* Has used any investigational drug within 30 days preceding study participation.~* Suffers from a condition, which, in the opinion of the Investigator, would compromise his or her safety.~* Suffers from a condition which, in the opinion of the Investigator, would compromise the quality of the data.~* Has a known allergy to any of the products that are part of this protocol~* Suffers from a condition which, in the opinion of the Investigator, would seriously interfere negatively with the normal parameters of immune response to an infection.~* Is using any of the prohibited concomitant medications or treatments

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).